Eight unrelated patients with Hunter syndrome were investigated for expression of iduronate-2-sulfatase (IDS) mRNA by reverse transcription (RT) linked to polymerase chain reaction (PCR), or RT-PCR. The entire coding region was studied by amplification of two overlapping segments of 0.7 and 1.1 kb.
The effect of four mutations on the expression of iduronate-2-sulfatase in mucopolysaccharidosis type II
β Scribed by Gloria Bonuccelli; Paola Di Natale; Fabio Corsolini; Guglielmo Villani; Stefano Regis; Mirella Filocamo
- Book ID
- 117617842
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 195 KB
- Volume
- 1537
- Category
- Article
- ISSN
- 0925-4439
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Communicated by Francesco Giannelli Mucopolysaccharidosis type I1 (MI'S 11) is an X-chromosomal storage disorder due to deficiency of the lysosomal enzyme iduronate-2-sulfatase
Communicated by Jurgen Horsr Genomic DNA and cDNA from fibroblasts from nine unrelated German patients with X-linked iduronate-2-sulfatase (IDS) deficiency showing variable clinical manifestation were screened for point mutations and small structural aberrations. Direct sequencing revealed a splice
Hunter disease, mucopolysaccharidosis type II or MPS II (OMIM \*309900) iduronate-2-sulfatase : IDS (GDB) Abbreviations amplification refractory system : ARMS, iduronate-2-sulfatase : IDS
Mucopolysaccharidosis type II (MPS2, or Hunter syndrome), rare X-linked lysosomal storage disorder, results from deleterious mutations in the iduronate-2-sulfatase (IDS) gene. We report here the mutational analysis of a total of 40 unrelated Italian MPS II patients ranging from mild to severe phenot
A number of mutations in the X-chromosomal human iduronate-2-sulphatase gene have now been identified as the primary genetic defect leading to the clinical condition known as Hunter syndrome or mucopolysaccharidosis type 11. The mutations that are tabulated include different deletions, splice-site a